Advanced in Major Depression

Huafang Z. Li

600 Wan Ping Nan Road, 
Shanghai, CN 
Advanced in Major Depression
600 Wan Ping Nan Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Huafang Li practices in Shanghai, China. Li is rated as an Advanced expert by MediFind in the treatment of Major Depression. Their top areas of expertise are Major Depression, Schizophrenia, Retrograde Ejaculation, and Arterial Embolism.

Their clinical research consists of co-authoring 95 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 22 articles in the study of Major Depression.

Locations

600 Wan Ping Nan Road, Shanghai, 200030, China
Other Locations
4/F, 604 Lingling Road, Shanghai, 200030, China
Wanpingnan Road #600, Shanghai, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Single Ascending Dose of NH102 in Healthy Subjects
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Single Ascending Dose of NH102 in Healthy Subjects
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Phase: Phase 1
A Randomized, Double-blinded, Placebo-controlled, Dose-escalation Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 Sustained-release Tablets in Healthy Subjects
A Randomized, Double-blinded, Placebo-controlled, Dose-escalation Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 Sustained-release Tablets in Healthy Subjects
Enrollment Status: Completed
Publish Date: January 29, 2024
Intervention Type: Drug
Study Phase: Phase 1
Proof Of Concept Study of Orcinoside in the Treatment of Major Depressive Disorder(MDD): a Randomized, Double-Blind, Placebo-Paralleled,Dose-Finding, Multicenter Clinical Trial
Proof Of Concept Study of Orcinoside in the Treatment of Major Depressive Disorder(MDD): a Randomized, Double-Blind, Placebo-Paralleled,Dose-Finding, Multicenter Clinical Trial
Enrollment Status: Completed
Publish Date: September 23, 2021
Intervention Type: Drug
Study Phase: Phase 2
Evaluation of Safety and Pharmacokinetic Profiles of a Single-dose HHT201 in Healthy Subjects
Evaluation of Safety and Pharmacokinetic Profiles of a Single-dose HHT201 in Healthy Subjects
Enrollment Status: Completed
Publish Date: September 29, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 3 Less Clinical Trials

95 Total Publications

Efficacy and Safety of Ammoxetine in Major Depressive Disorder: A Randomized Clinical Trial.
Efficacy and Safety of Ammoxetine in Major Depressive Disorder: A Randomized Clinical Trial.
Journal: JAMA network open
Published: September 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Li's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile